The future of dental sleep medicine (DSM) is being explored by the American Academy of Dental Sleep Medicine (AADSM) through a task force led by Dr. Jean-François Masse and Dr. Rose Sheats. The task force reviewed recent scientific literature over the past decade to critically evaluate novel treatments for sleep apnea and snoring beyond oral appliances. The review considered recent developments in the field, including the emergence of new medications for diabetes and obesity, the potential withdrawal of CPAP machines by Philips, the questioning of the validity of AHI for sleep apnea diagnosis, debates on diagnostic techniques, the rise of artificial intelligence in sleep apnea analysis, and new technologies like wearables and sleep apps. The task force's findings were presented at the SLEEP meeting in June and will be discussed in physician journals. The report highlights the need for more research but also provides guidance on existing treatments. For example, it addresses the recent New York Times article on frenectomies, which has sparked debate in the dental community. The report focuses on treatments for obstructive sleep apnea (OSA) and snoring in both pediatric and adult patients. It emphasizes the importance of evidence-based decision-making for dentists. The task force's work represents the current state of knowledge based on recent scientific publications, and as more data become available, the understanding will continue to evolve. The authors hope this document will stimulate discussions within the dental sleep medicine community about the future of the profession. They thank Dr. Sheats for her leadership in this extensive work. The article is published in the Journal of Dental Sleep Medicine.The future of dental sleep medicine (DSM) is being explored by the American Academy of Dental Sleep Medicine (AADSM) through a task force led by Dr. Jean-François Masse and Dr. Rose Sheats. The task force reviewed recent scientific literature over the past decade to critically evaluate novel treatments for sleep apnea and snoring beyond oral appliances. The review considered recent developments in the field, including the emergence of new medications for diabetes and obesity, the potential withdrawal of CPAP machines by Philips, the questioning of the validity of AHI for sleep apnea diagnosis, debates on diagnostic techniques, the rise of artificial intelligence in sleep apnea analysis, and new technologies like wearables and sleep apps. The task force's findings were presented at the SLEEP meeting in June and will be discussed in physician journals. The report highlights the need for more research but also provides guidance on existing treatments. For example, it addresses the recent New York Times article on frenectomies, which has sparked debate in the dental community. The report focuses on treatments for obstructive sleep apnea (OSA) and snoring in both pediatric and adult patients. It emphasizes the importance of evidence-based decision-making for dentists. The task force's work represents the current state of knowledge based on recent scientific publications, and as more data become available, the understanding will continue to evolve. The authors hope this document will stimulate discussions within the dental sleep medicine community about the future of the profession. They thank Dr. Sheats for her leadership in this extensive work. The article is published in the Journal of Dental Sleep Medicine.